Concepedia

Gerwyn Bish

GB

Statistics

Publications

13

Citations

440

H-Index

11

Active since

2006

Affiliations

Pfizer (United Kingdom)(Current)

University of Bath

Pfizer (United States)

Gerwyn Bish is an author at Pfizer (United Kingdom) specializing in medicinal chemistry, natural sciences, and chemistry.

Publications per year

2006–2012

13

Publications

13

Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit

Paul V. Fish, P. Filippakopoulos, Gerwyn Bish et al. · Journal of Medicinal Chemistry · 2012 · 196 citations · Full text

, , +17

Rhodium-catalysed addition of organotrialkoxysilanes to α-substituted acrylic esters

Jonathan D. Hargrave, Jennifer Herbert, Gerwyn Bish et al. · Organic & Biomolecular Chemistry · 2006 · 30 citations

, , +13

N-(1,2-Diphenylethyl)piperazines: A new class of dual serotonin/noradrenaline reuptake inhibitor

M. Jonathan Fray, Gerwyn Bish, Alan D. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 29 citations · Full text

, , +10

Peptide modification through site-selective residue interconversion: application of the rhodium-catalysed 1,4-addition of aryl siloxanes and boronates

C. J. Chapman, Jonathan D. Hargrave, Gerwyn Bish et al. · Tetrahedron · 2008 · 29 citations

, , +5

Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection

Thien-Duc Tran, David C. Pryde, Peter Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 27 citations · Full text

, , +10

1–5 of 13